Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

The flowchart of the study design.

KM, Kaplan-Meier; IDI, integrated discrimination improvement; NRI, net reclassification improvement; ROC, receiver operating characteristic; CVD, cardiovascular diseases.

More »

Fig 1 Expand

Fig 2.

Minimal depth variables in rank order, most important at the top.

Vertical dashed line indicates the maximal minimal depth for important variables. Indicators for nomogram A (A), nomogram B (B), nomogram C (C), nomogram D (D). SBP, systolic blood pressure; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.

More »

Fig 2 Expand

Table 1.

Baseline characteristics of the training and testing sets.

More »

Table 1 Expand

Fig 3.

Nomogram A constructed using the independent prognostic factors predicting the three- and five-year CVD-free (fatal/non-fatal) survival. Q, quantile; FG, fasting glucose; SBP, systolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SUA, serum uric acid; T2D, type 2 diabetes mellitus; BMI, body mass index; HR, heart rate.

More »

Fig 3 Expand

Fig 4.

Nomogram B constructed using the independent prognostic factors predicting the three- and five-year CVD-free (fatal/non-fatal) survival. Q, quantile; FG, fasting glucose; SBP, systolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SUA, serum uric acid; T2D, type 2 diabetes mellitus; BMI, body mass index; HR, heart rate.

More »

Fig 4 Expand

Fig 5.

Nomogram C constructed using the independent prognostic factors predicting the three- and five-year CVD-free (fatal/non-fatal) survival. Q, quantile; FG, fasting glucose; SBP, systolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SUA, serum uric acid; T2D, type 2 diabetes mellitus; BMI, body mass index; HR, heart rate.

More »

Fig 5 Expand

Fig 6.

Nomogram D constructed using the independent prognostic factors predicting the three- and five-year CVD-free (fatal/non-fatal) survival. Q, quantile; FG, fasting glucose; SBP, systolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SUA, serum uric acid; T2D, type 2 diabetes mellitus; BMI, body mass index; HR, heart rate.

More »

Fig 6 Expand

Table 2.

Prediction performance of the nomogram for CVD-free survival.

More »

Table 2 Expand

Fig 7.

Time-dependent AUC curves of the nomograms for the prediction of CVD-free survival in the training set (A, B, C) and testing set (D, E, F).

More »

Fig 7 Expand

Fig 8.

Calibration curves of the nomogram A.

(A) Three-year and (B) five-year CVD-free (fatal/non-fatal) survival in the training set. (C) Three-year and (D) five-year CVD-free survival in the testing set.

More »

Fig 8 Expand

Fig 9.

Calibration curves of the nomogram B.

(A) Three-year and (B) five-year CVD-free (fatal/non-fatal) survival in the training set. (C) Three-year and (D) five-year CVD-free survival in the testing set.

More »

Fig 9 Expand

Fig 10.

Calibration curves of the nomogram C.

(A) Three-year and (B) five-year CVD-free (fatal/non-fatal) survival in the training set. (C) Three-year and (D) five-year CVD-free survival in the testing set.

More »

Fig 10 Expand

Fig 11.

Calibration curves of the nomogram D.

(A) Three-year and (B) five-year CVD-free (fatal/non-fatal) survival in the training set. (C) Three-year and (D) five-year CVD-free survival in the testing set.

More »

Fig 11 Expand

Fig 12.

Decision curve analysis of CVD-free survival nomograms.

The DCA for three- (A), five-year (B), CVD-free survival prediction in training set and for three - (C) and five-year (D) CVD-free survival prediction in the testing set.

More »

Fig 12 Expand

Fig 13.

Receiver operating characteristic of the nomograms for three- (A, B, C) and five-year (D, E, F) CVD-free survival prediction in the training set.

More »

Fig 13 Expand

Fig 14.

Receiver operating characteristic of the nomograms for three- (A, B, C) and five-year (D, E, F) CVD-free survival prediction in the testing set.

More »

Fig 14 Expand

Table 3.

Comparison of NRI and IDI among nomograms predicting three- and five-year CVD-free survival.

More »

Table 3 Expand

Fig 15.

Kaplan–Meier curves of CVD-free survival (fatal/non-fatal) for risk classification based on the nomogram A scores (A), the nomogram B scores (B), the nomogram C scores (C), and the nomogram D scores (D) in the training set. HR, hazard ratio.

More »

Fig 15 Expand